Progression, Management, and Clinical Outcomes of Coronary Artery Aneurysms
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Study ID
- NCT07764081
- Status
- Recruiting
Conditions
- Aneurysms
- Coronary Artery Disease
- Coronary Intervention
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Study Details
This study aimed to characterize the progression and risk fators of coronary artery aneurysms, and copmpare the outcomes across different management strategies
Key Dates
- First listed
- Aug 13, 2026
- Start date
- Jul 31, 2026
- Status verified
- Aug 2026
- Primary completion
- Dec 31, 2027
- Completion
- Aug 30, 2028
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Coronary Artery AneurysmsPatients with angiographically confirmed coronary artery aneurysms, defined as coronary dilation ≥1.5 times than the adjacent reference vessel diameter,
Primary Outcome Measure
Progression of coronary artery aneurysm [ Time Frame: 6-12 months ]
Central Contacts
- Fei Ye, MD18951670287
- Yi-fei Wang, MD18852577798
Related Studies
- Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem CellsEnrolling By Invitation · Scripps Translational Science Institute · La Jolla, California
- Product Surveillance RegistryRecruiting · Medtronic · Birmingham, Alabama
- Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD)PHASE2 · Not Yet Recruiting · Cell>Point LLC · Oklahoma City, Oklahoma
- Factors Affect Outcomes in Cardiovascular SurgeryRecruiting · University of California, Davis · Sacramento, California